![Timothy Clackson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Clackson
Algemeen Directeur bij
IDRx, Inc.
Profiel
Timothy P.
Clackson currently works at IDRx, Inc., as President, Chief Executive Officer & Director from 2024.
Dr. Clackson also formerly worked at Theseus Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2021 to 2023, Forma Therapeutics Holdings, Inc., as Independent Non-Executive Director from 2018 to 2022, F-Star Therapeutics, Inc. (United States), as Independent Director, Elevation Oncology, Inc., as Independent Director from 2020 to 2025, Massachusetts Biotechnology Council, as Director, Forma Therapeutics, Inc., as Director, ARIAD Pharmaceuticals, Inc., as CSO, President-Research & Development from 2010 to 2017, and Xilio Therapeutics, Inc., as President & Chief Technology Officer from 2018 to 2021.
Dr. Clackson received his undergraduate degree from the University of Oxford and doctorate degree from the University of Cambridge.
Actieve functies van Timothy Clackson
| Bedrijven | Functie | Begin |
|---|---|---|
IDRx, Inc.
 IDRx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment | Algemeen Directeur | 12-03-2024 |
Eerdere bekende functies van Timothy Clackson
| Bedrijven | Functie | Einde |
|---|---|---|
| ELEN ONCO | Directeur/Bestuurslid | 23-07-2025 |
| THESEUS PHARMACEUTICALS, INC. | Algemeen Directeur | 07-12-2023 |
| FORMA THERAPEUTICS HOLDINGS, INC. | Directeur/Bestuurslid | 14-10-2022 |
| XILIO THERAPEUTICS, INC. | President | 01-04-2021 |
| ARIAD PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2017 |
Opleiding van Timothy Clackson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
61
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Forma Therapeutics, Inc.
 Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Health Technology |
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes novel therapeutics to transform the patient living | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
Elevation Oncology, Inc.
 Elevation Oncology, Inc. BiotechnologyHealth Technology Develops elevating precision medicines for cancer treatment | Health Technology |
IDRx, Inc.
IDRx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment | Health Technology |
